Fosdagrocorat

DB12198InvestigationalSmall molecule

Fosdagrocorat has been used in trials studying the treatment and basic science of Rheumatoid Arthritis.

Mechanism: Pharmacologically active on Glucocorticoid receptor
Curator reviewed
Formula / weight: C₂₉H₃₀F₃N₂O₅P · 574.537 g/mol (avg)
Code names: PF-04171327

Resolves to

Compound

Structure

InChIKeyBVXLAHSJXXSWFF-KEKPKEOLSA-NSMILES[H][C@]12CCC3=C(C=CC(=C3)C(=O)NC3=C(C)N=CC=C3)[C@]1(CC1=CC=CC=C1)CC[C@](C2)(OP(O)(O)=O)C(F)(F)F

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Fosdagrocorat, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.